Show an ad over header. AMP

I am the second

Johnson & Johnson to resume COVID vaccine rollout in Europe

Johnson & Johnson announced Tuesday it would resume the rollout of its coronavirus vaccine in Europe after the European Medicines Agency (EMA) said unusual blood clots should be listed as a "very rare" side effect of the company's vaccine, but that the benefits of the shot still outweigh the risks.

Why it matters: Johnson & Johnson was set to send 50 million doses of its one-shot coronavirus vaccine to the European Union before it delayed it's European rollout earlier in April "out of an abundance of caution" over rare blood clotting events.

Keep reading... Show less

Related Articles

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories